Stock of the Day for October 24, 2024

Merck & Co., Inc. Stock Report

Merck & Co., Inc.
MRK 90-day performance NYSE:MRK Merck & Co., Inc.
Current Price
$78.17
-3.58 (-4.38%)
(As of 03:59 PM ET)
30 Day Performance
-4.38%
  
  
90 Day Performance
-5.98%
  
  
1 Year Performance
-30.90%
  
  
Market Capitalization
$196.29B
P/E Ratio
12.04
Dividend Yield
4.14%
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

MRK Company Calendar

JUN. 16, 2025
Ex-Dividend for 7/8 Dividend
JUL. 8, 2025
Dividend Payable
JUL. 29, 2025
Last Earnings
JUL. 31, 2025
Today
DEC. 31, 2025
Fiscal Year End

Recent Merck & Co., Inc. News

Natixis Advisors LLC Sells 175,562 Shares of Merck & Co., Inc. (NYSE:MRK)
NorthRock Partners LLC Cuts Holdings in Merck & Co., Inc. (NYSE:MRK)
SSA Swiss Advisors AG Takes Position in Merck & Co., Inc. (NYSE:MRK)
Tower Bridge Advisors Sells 4,200 Shares of Merck & Co., Inc. (NYSE:MRK)
Dearborn Partners LLC Sells 57,396 Shares of Merck & Co., Inc. (NYSE:MRK)
Eastern Bank Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK)
This report was written on July 31, 2025. This report first appeared on MarketBeat.com.